We are excited to announce that MedWorks Media's flagship journal, Psychopharmacology Bulletin, has been featured in EBSCO's latest issue of New & Notable. MedWorks Media (Psychopharmacology Bulletin) has partnered with EBSCO Information Services for over 15 years. EBSCO Information Services provides a complete and optimized research solution comprised [...]
The Effect of Food on the Absorption of Oral Ziprasidone By Jeffrey J.Miceli, PhD, Paul Glue, MD, PhD, Jeffrey Alderman, PhD, and Keith Wilner, PhD
PHILADELPHIA — New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 months of treatment was 45% in all patients but higher in those with Dravet syndrome, among the most severe types of epilepsy. The [...]
The US Food and Drug Administration (FDA) has approved a chewable tablet form of extended-release methylphenidate (QuilliChew ER, Pfizer Inc) for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the company announced today. The chewable product will be available in tablet form in strengths of 20, 30, and [...]
HUNTINGTON BEACH, California ― Results of a large, multicenter, randomized trial show that extended-release (ER) naltrexone (Vivitrol, Alkermes, Inc) can effectively prevent opioid relapse among a particularly vulnerable population: adults involved in the criminal justice system. "Extended-release naltrexone is better known now, but this study began prior to its approval [...]
What is this new insanity drug of abuse known as gravel or flakka? Recent news reports detail a man, who thought he was being chased by dozens of cars, using every ounce of strength to break the glass of a police station entrance door. Another man ran naked down the [...]
Rexulti: New treatment for schizophrenia and major depressive disorder approved and released by FDA On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). [...]
Repetitive training, used widely in autism education, may hinder the learning process by promoting inflexibility, a new study with potentially "earthshaking" implications shows. The study unexpectedly found that repetitive training, a technique widely used in intervention and education for people with autism spectrum disorder (ASD), hinders the learning process by [...]
The Centers for Disease Control and Prevention (CDC) has issued a warning regarding increases in fentanyl drug confiscations and a potential increased risk for fentanyl-related overdose fatalities. According to the CDC, reports from the National Forensic Laboratory Information System, a program of the Drug Enforcement Administration's (DEA's) Office of Diversion [...]
CHICAGO — Taking a probiotic strain of Bifidobacterium longumreduced physiologic and psychological stress and led to a modest improvement in memory in a small pilot study of healthy men. The study builds on preclinical studies that identified this B longumstrain as a "putative psychobiotic" with beneficial effects on stress-related behaviors, [...]